Pomalidomide-C4-COOH

 CAS No.: 2225940-48-5  Cat No.: BP-100158  Purity: ≥95% 4.5  

Pomalidomide-C4-COOH is a high-purity E3 Ligase Ligand-Linker Conjugate designed for advanced PROTAC (Proteolysis Targeting Chimera) drug development and targeted protein degradation research. This compound features a pomalidomide-based E3 ligase ligand conjugated to a four-carbon alkyl linker terminated with a carboxylic acid (COOH) functional group, facilitating convenient attachment to target protein ligands or warheads during PROTAC synthesis. As a derivative of pomalidomide, this molecule recruits the CRBN E3 ubiquitin ligase, enabling the formation of bifunctional PROTACs that mediate ubiquitination and subsequent proteasomal degradation of target proteins. Pomalidomide-C4-COOH is widely used in academic and pharmaceutical research to investigate new drug modalities, particularly for challenging or 'undruggable' proteins in oncology, neurodegenerative diseases, and other therapeutic areas. Its reliable performance and modular structure make it an essential building block for custom PROTAC design and molecular glue development.

Pomalidomide-C4-COOH

Structure of 2225940-48-5

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
E3 Ligase Ligand-Linker Conjugate
Molecular Formula
C18H19N3O6
Molecular Weight
373.36
Appearance
Yellow Solid

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Purity
≥95%
Solubility
Soluble in DMF, DMSO
Appearance
Yellow Solid
Storage
Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years)
IUPACName
5-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]pentanoic acid
Synonyms
Pomalidomide-C4-acid; Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-; 5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentanoic acid; 5-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]pentanoic acid; 5-{[2-(2,6-Dioxo-3-piperidinyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}pentanoic acid; Pomalidomide 4'-alkylC4-acid; JUN 40485; JUN-40485; Thalidomide-NH-C4-COOH
Boiling Point
712.2±60.0°C at 760 mmHg
Density
1.5±0.1 g/cm3
InChI Key
JUPYDAIBDNUUIF-UHFFFAOYSA-N
InChI
InChI=1S/C18H19N3O6/c22-13-8-7-12(16(25)20-13)21-17(26)10-4-3-5-11(15(10)18(21)27)19-9-2-1-6-14(23)24/h3-5,12,19H,1-2,6-9H2,(H,23,24)(H,20,22,25)
Canonical SMILES
C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCCCC(=O)O

Background Introduction

Pomalidomide-C4-COOH is a specialized E3 ligase ligand-linker conjugate, which integrates the well-characterized E3 ligase binder pomalidomide with a carboxylic acid-functionalized four-carbon linker. This compound serves as a critical intermediate in the development of targeted protein degradation technologies like PROTACs (Proteolysis Targeting Chimeras), designed to harness the body’s own ubiquitin-proteasome system for the selective elimination of disease-causing proteins.

Mechanism

The mechanism of Pomalidomide-C4-COOH centers around its dual-functionality. Pomalidomide acts as a ligand for the E3 ubiquitin ligase CRBN (Cereblon), effectively recruiting the E3 ligase complex when incorporated into bifunctional molecules. The appended C4 aliphatic linker, terminated with a carboxylic acid group, enables facile conjugation to various target protein ligands or other molecular scaffolds. In a PROTAC construct, Pomalidomide-C4-COOH tethers the E3 ligase to a specific target protein, promoting its ubiquitination and subsequent proteasomal degradation.

Applications

Pomalidomide-C4-COOH is widely used in chemical biology and drug discovery as a fundamental building block for synthesizing PROTAC molecules. Its applications include the development of custom PROTACs for degrading oncogenic proteins, creating molecular probes to study protein function, and contributing to the validation of novel therapeutic targets. Researchers select Pomalidomide-C4-COOH due to its reliability, efficiency in E3 ligase recruitment, and ease of chemical modification, making it an essential tool in the toolkit for targeted protein degradation strategies.

• Carboxyl-functionalized linker enables efficient amide bond formation for customized PROTAC assembly.
• Designed for high-affinity CRBN E3 ligase recruitment, optimizing targeted protein degradation strategies.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g
Historical Records:

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
Germany
Inquiry Basket